SpecStream

Data / Form D filings / Amani Therapeutics, Inc.

Amani Therapeutics, Inc.: Form D filing

Amani Therapeutics, Inc., a health care company in New York, NY, filed a Form D with the SEC in 2026. The latest, on October 1, 2026, reports $35 million sold of a $60 million offering to 5 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Get filings like this oneWeekly RSS feed

Company details from the filing

Address
40 10TH AVENUE FLOOR 7, New York, NY, 10014
Phone
(646) 597-6980
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2025
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2099941

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Oct 1New notice$59,999,999$34,999,999$25,000,0005Sep 16sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Alice LeeExecutive Officer
-- RTW Holdings VI, LLCPromoter
Robert SwobodaExecutive Officer
Lauren CujeDirector
Peter FongDirector
Connor WilliamsDirector

Other health care companies in New York that filed recently

Every Form D from the week of Sep 28 · All recent filings in New York · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Amani Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.